OCTASA

Identification of Octasa

No description

Google image searchProduct monograph

Active ingredient

mesalazine, 800 MG

DIN: 02465752

Dosage form(s): TABLET (DELAYED-RELEASE)

Route(s) of administration: ORAL

Description: ALSO KNOWN AS MESALAMINE

Schedule: Prescription

Company: TILLOTTS PHARMA AG

Date: 28-SEP-2022

ATC:

Reference brand drug: Asacol, Mesasal, Mezavant, Mezera, Octasa, Pentasa, Salofalk

Pharmaceutical standard: MFR

Search on Google